Newborn screening platform for lysosomal storage disorders with FDA clearance and CE mark

SEEKER is a high throughput laboratory solution that quantitatively measures the activity of lysosomal enzymes from newborn dried blood spot specimens. Reduced activity of these enzymes may be indicative of:

Mucopolysaccharidosis Type I (MPS I), Pompe, Gaucher or Fabry disease

Image

Everything your lab needs for LSD screening in one small workstation

SEEKER Features:

  • Flexible
  • Cost-effective
  • Fast results
  • Simple operation

SEEKER Brochure

Want to speak with a Baebies team member?

CONTACT US

Lab Products Advisory Board